Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 17 of BIOVIE INC.'s SEC filings and found 18 warrant series, 1 convertible, 2 ATM programs, 2 shelf registrations, 3 S-1 registrations and 2 completed offerings on file for BIVI. The latest dilution event on file is ATM sales on Sep 11, 2026. Analysis updated Sep 17, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
BCDABioCardia, Inc.
KTTAPasithea Therapeutics Corp.
DYAIDyadic International, Inc.
DAREDare Bioscience, Inc.
TCRXTScan Therapeutics, Inc.
HINDVyome Holdings, Inc.
CTXRCitius Pharmaceuticals, Inc.
NCELNewcelX Ltd. Ordinary Shares
SYBXSynlogic, Inc.
RADXRadiopharm Theranostics Limited American Depositary Shares
CLRBCellectar Biosciences, Inc.
PBMPsyence Biomedical Ltd.
LPCNLipocine Inc.
ATYRaTyr Pharma, Inc.
MRKRMarker Therapeutics, Inc.